Search Medical Condition
Please enter condition
Please choose location

Monteporeiro, Spain Clinical Trials

A listing of Monteporeiro, Spain clinical trials actively recruiting patients volunteers.

RESULTS

Found (36) clinical trials

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

In the majority of European countries, the primary management of chronic heart failure patients is performed by General Practitioners in collaboration with cardiologists (specialists). Previous studies have shown that many patients suffering from CHF do not receive optimal pharmacological and/or device treatment for their disease. An increase in natriuretic peptides ...

Phase

0.24 miles

Learn More »

Chronotherapy With Low-dose Aspirin for Primary Prevention

Brief summary: Aspirin (ASA) has been shown to provide marked benefits in primary and secondary prevention of cardiovascular events. Substantial evidence suggests that low-dose ASA therapy should also be used as a primary prevention strategy in men and women with diabetes who are at high cardiovascular risk. On the other ...

Phase

0.7 miles

Learn More »

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

Ambulatory blood pressure (BP) measurements (ABPM) correlate more closely with target organ damage and cardiovascular events than clinical cuff measurements. ABPM reveals the significant circadian variation in BP, which in most individuals presents a morning increase, small post-prandial decline, and more extensive lowering during nocturnal rest. However, under certain pathophysiological ...

Phase

0.7 miles

Learn More »

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

The drug being tested in this study is called vedolizumab subcutaneous (vedolizumab SC). Vedolizumab SC is being tested to assess its long-term safety and effectiveness in treating participants with UC or CD. This study will look at the long-term side effects and response/remission of UC and CD in participants who ...

Phase

1.35 miles

Learn More »

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Oversight Authorities continued: Colombia- pending regulatory approval

Phase

1.59 miles

Learn More »

PROSTAC: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Docetaxel or Cabazitaxel

Observational study to analyze prognostic factors in castration resistant prostate cancer patients.

Phase N/A

1.59 miles

Learn More »

Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib

This is a nation-wide retrospective observational study which will be performed in 50 centres in Spain, geographically representative of all regions, with at least 5 patients treated with first-line pazopanib for mRCC in daily clinical practice since April 2011 (date of approval of pazopanib in Spain), January 2016. Pazopanib is ...

Phase N/A

1.59 miles

Learn More »

PROSABI: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Abiraterone

Prospective Multi-centre Studies of Prognostic Factors in Castration resistant PROState Cancer Treated With Abiraterone (PROSABI)

Phase N/A

1.59 miles

Learn More »

Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

The purpose of this study is to evaluate, in terms of overall survival, the benefit of monoclonal antibodies in the start time of the diagnosis of advanced disease or administer a deferred basis after progression to treatment with chemotherapy alone.

Phase N/A

1.59 miles

Learn More »

PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Radium-223

Observational study to analyze prognostic factors in castration resistant prostate cancer patients.

Phase N/A

1.59 miles

Learn More »